Skip to main content


Table 1 Exposure (mean value) of paclitaxel in plasma, tumor, liver, and spleen following intravenous administration

From: Nanosuspension delivery of paclitaxel to xenograft mice can alter drug disposition and anti-tumor activity

Tissue AUC0-8 (μM × h) Formulation
  Cremophor EL:ethanol Nanosuspension
Plasma 74.7 2.1
Tumor 52.1 17.5
Liver 269.1 1,701.1
Spleen 85.2 147.5